• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿路结石病的合理评估

Rational evaluation of urinary stone disease.

作者信息

Hesse Albrecht, Straub Michael

机构信息

Department of Urology, University of Bonn, Bonn, Germany.

出版信息

Urol Res. 2006 Apr;34(2):126-30. doi: 10.1007/s00240-005-0024-2. Epub 2006 Feb 1.

DOI:10.1007/s00240-005-0024-2
PMID:16450128
Abstract

This article outlines the recent state of the art in the metabolic diagnosis of stone disease. The current literature in the field of urolithiasis-including the existing German and EAU-Guidelines as well as the Conference Book of the 1st International Consultation on Stone Disease-was critically reviewed. As far as possible the references were rated according to the EBM criteria. The occurrence of stone disease in the western world is increasing greatly. Modern lifestyle, dietary habits and excess weight-problems of affluent societies-are emerging as the important promoters of the "stone boom" in the new millennium. This even affects children, whose stone prevalence is otherwise significantly less than that of adults. Criteria for the high-risk group of stone formers were clearly defined. A diagnostic standard is formulated for the basic and the elaborate metabolic evaluation of a stone patient. The diagnostic pathways for the most important stone types and metabolic disorders, respectively, are described. The present concept allows a precise risk classification of each stone former and facilitates the decision whether stone-specific measures in addition to the basic metaphylaxis are recommendable or not.

摘要

本文概述了结石病代谢诊断的最新技术水平。对尿石症领域的当前文献——包括现有的德国和欧洲泌尿外科学会指南以及第一届国际结石病咨询会议的会议手册——进行了批判性综述。尽可能根据循证医学标准对参考文献进行评级。西方世界结石病的发病率正在大幅上升。现代生活方式、饮食习惯和超重——富裕社会的问题——正成为新千年“结石热潮”的重要推动因素。这甚至影响到儿童,否则他们的结石患病率明显低于成年人。明确界定了结石形成高危人群的标准。为结石患者的基础和详细代谢评估制定了诊断标准。分别描述了最重要的结石类型和代谢紊乱的诊断途径。目前的概念允许对每个结石形成者进行精确的风险分类,并有助于决定除基本预防措施外是否推荐采取针对结石的措施。

相似文献

1
Rational evaluation of urinary stone disease.尿路结石病的合理评估
Urol Res. 2006 Apr;34(2):126-30. doi: 10.1007/s00240-005-0024-2. Epub 2006 Feb 1.
2
Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline.结石病的诊断与预防。结石病国家工作委员会针对即将出台的德国尿路结石指南的共识概念。
World J Urol. 2005 Nov;23(5):309-23. doi: 10.1007/s00345-005-0029-z. Epub 2005 Nov 29.
3
Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.代谢评估和预防尿路结石患者复发:EAU 指南。
Eur Urol. 2015 Apr;67(4):750-63. doi: 10.1016/j.eururo.2014.10.029. Epub 2014 Nov 20.
4
Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.特发性复发性草酸钙尿石症男性患者餐后尿中草酸钙成核与磷酸钙成核及结石形成强度有关吗?有助于深入了解尿游离柠檬酸盐和蛋白质可能作用的研究。
Clin Chem Lab Med. 2004 Mar;42(3):283-93. doi: 10.1515/CCLM.2004.052.
5
Association between body mass index, lipid profiles, and types of urinary stones.体重指数、血脂谱与尿石类型的关系。
Ren Fail. 2012;34(9):1140-3. doi: 10.3109/0886022X.2012.713298. Epub 2012 Aug 14.
6
Course of calcium stone disease without treatment. What can we expect?未经治疗的钙结石病病程。我们能预期到什么?
Eur Urol. 2000 Mar;37(3):339-44. doi: 10.1159/000052367.
7
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.肾结石形成的尿液危险因素的饮食治疗。CLU工作组综述
Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105.
8
The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.饮食干预对复发性草酸钙结石患者结石形成的尿液危险因素的疗效。
J Urol. 2005 May;173(5):1601-5. doi: 10.1097/01.ju.0000154626.16349.d3.
9
Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.草酸钙结石患者肠道产甲酸草酸杆菌定植及其与尿草酸的关系
J Endourol. 2003 Apr;17(3):173-6. doi: 10.1089/089277903321618743.
10
[What kind of stone prevention for whom? Risk-adjusted metaphylaxis following urinary stone disease].
Urologe A. 2006 Nov;45(11):1387-8, 1390-1. doi: 10.1007/s00120-006-1224-2.

引用本文的文献

1
Comparison of the bone mineral density status of patients with kidney stones stratified by stone composition.比较按结石成分分层的肾结石患者的骨矿物质密度状况。
World J Urol. 2024 Jan 20;42(1):42. doi: 10.1007/s00345-023-04727-y.
2
HIV medication-based urolithiasis.基于抗逆转录病毒药物的尿路结石症
Clin Kidney J. 2014 Apr;7(2):121-6. doi: 10.1093/ckj/sfu008. Epub 2014 Mar 11.
3
Medication-based urolithiasis and atazanavir.基于药物的尿路结石与阿扎那韦

本文引用的文献

1
Quality control in urinary stone analysis: results of 44 ring trials (1980-2001).尿石分析中的质量控制:44次环形试验的结果(1980 - 2001年)
Clin Chem Lab Med. 2005;43(3):298-303. doi: 10.1515/CCLM.2005.051.
2
Dependence of oxalate absorption on the daily calcium intake.
J Am Soc Nephrol. 2004 Jun;15(6):1567-73. doi: 10.1097/01.asn.0000127864.26968.7f.
3
Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000.德国1979年与2000年尿路结石患病率及发病率比较研究。
CMAJ. 2011 Aug 9;183(11):E748-51. doi: 10.1503/cmaj.100019. Epub 2011 Mar 28.
4
Evaluation of children with urolithiasis.小儿尿石症的评估
Indian J Urol. 2007 Oct;23(4):420-7. doi: 10.4103/0970-1591.36717.
5
[What kind of stone prevention for whom? Risk-adjusted metaphylaxis following urinary stone disease].
Urologe A. 2006 Nov;45(11):1387-8, 1390-1. doi: 10.1007/s00120-006-1224-2.
Eur Urol. 2003 Dec;44(6):709-13. doi: 10.1016/s0302-2838(03)00415-9.
4
Time trends in reported prevalence of kidney stones in the United States: 1976-1994.美国1976 - 1994年报告的肾结石患病率的时间趋势
Kidney Int. 2003 May;63(5):1817-23. doi: 10.1046/j.1523-1755.2003.00917.x.
5
Reference range for gastrointestinal oxalate absorption measured with a standardized [13C2]oxalate absorption test.通过标准化的[13C2]草酸盐吸收试验测定的胃肠道草酸盐吸收参考范围。
J Urol. 2003 Feb;169(2):687-90. doi: 10.1097/01.ju.0000051637.63068.92.
6
[Urinary calculi. 1: Epidemiology, laboratory diagnosis, genetics and infections].
Urologe A. 2002 Sep;41(5):496-506; quiz 507-8. doi: 10.1007/s00120-002-0235-x.
7
Guidelines on urolithiasis.尿石症指南。
Eur Urol. 2001 Oct;40(4):362-71. doi: 10.1159/000049803.
8
Experience with the [13C2]oxalate absorption test.
Isotopes Environ Health Stud. 2000;36(1):11-20. doi: 10.1080/10256010008032929.
9
Course of calcium stone disease without treatment. What can we expect?未经治疗的钙结石病病程。我们能预期到什么?
Eur Urol. 2000 Mar;37(3):339-44. doi: 10.1159/000052367.
10
Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: application of a new test with [13C2]oxalate.草酸钙结石患者肠道草酸过度吸收:[13C2]草酸新检测方法的应用
J Am Soc Nephrol. 1999 Nov;10 Suppl 14:S329-33.